Evidence map›Paper›PMID 37543879›Full record

ArticleArchives of Iranian medicine2022

Six-Month Follow-up of COVID-19 Patients: Mortality and Related Factors.

Mohammad Haji Aghajani, Mohammad Sistanizad, Amirmohammad Toloui, Arian Madani Neishaboori, Asma Pourhoseingholi, Ziba Asadpoordezaki, Reza Miri, Mahmoud Yousefifard

Open access · hybridAbstract read
In one paragraph

Article in Archives of Iranian medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mohammad Haji AghajaniPrevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-4478-4025
Mohammad SistanizadPrevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amirmohammad TolouiPhysiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Arian Madani NeishabooriPhysiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Asma PourhoseingholiPrevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ziba AsadpoordezakiDepartment of Psychology, Maynooth University, Kildare, Ireland.
Reza MiriPrevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mahmoud YousefifardPhysiology Research Center, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-5181-4985
Iran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRNational University of Ireland, Maynooth · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrently, there is lack of evidence regarding the long-term follow-up of coronavirus disease 2019 (COVID-19) patients. The aim of this study is to present a 6-month follow-up of COVID-19 patients who were discharged from hospital after their recovery.

methodsThis retrospective cohort study was performed to assess the six-month follow-up of COVID-19 patients who were discharged from the hospital between February 18 and July 20, 2020. The primary outcome was 6-month all-cause mortality.

resultsData related to 614 patients were included to this study. Of these 614 patients, 48 patients died (7.8%). The cause of death in 26 patients (54.2%) was the relapse of COVID-19. Also, 44.2% of deaths happened in the first week after discharge and 74.4% in the first month. Risk factors of all-cause mortality included increase in age (odds ratio [OR]=1.09;

conclusionDeath is relatively common in COVID-19 patients after their discharge from hospital. In light of our findings, we suggest that elderly patients who experience a decrease in their mean arterial pressure, oxygen saturation and lymphocyte count during their hospitalization, should be discharged cautiously. In addition, we recommend that one-month follow-up of discharged patients should be take place, and urgent return to hospital should be advised when the first signs of COVID-19 relapse are observed.

Indexed as

COVID-19AgedFollow-Up StudiesHospitalizationHumansRecurrenceRetrospective StudiesRisk FactorsSARS-CoV-2COVID-19Long-term follow upMortalityRisk factors

Identifiers

PMID37543879
PMCPMC13661080
OpenAlexW4313729322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.